Why Was Envista Stock Up on Aug 6, 2026?

Envista shares are higher in pre-market trading today, recovering part of yesterday's 14.3% drop. That decline followed a quarter, reported August 5, 2026, in which the dental-products company beat both estimates — earnings of $0.41 per share versus $0.34 expected, and revenue of $730.5 million versus $716.05 million expected — and raised its full-year guidance for core sales growth, adjusted EBITDA, and adjusted EPS.

Envista owns a portfolio of more than 30 dental brands, including DEXIS imaging systems, Kerr restorative materials, Nobel Biocare implants, and Ormco orthodontics. A stock can fall on a beat-and-raise quarter when the size of the raise falls short of what was already priced in — the reaction measures the gap between results and expectations, not the quality of the results alone. Today's partial rebound suggests some of that gap is closing as investors digest the numbers with less urgency than the first reaction implied. For the full breakdown of yesterday's release, see our dated report on the beat-and-raise quarter.